
Adult Immunization
Latest News

Tapinarof Cream 1%, Shows Early and Durable Response in Children With Atopic Dermatitis

Vitamin D Dosing Tailored to Optimal Levels Reduced Risk of Recurrent MI by More Than Half

Cushing Syndrome: Clinical Features, Screening Tests, and When to Refer

Sublingual Epinephrine Film Well Tolerated in Children, Matches Efficacy Seen in Adults

FDA to Remove “Black Box” Warnings from Hormone Replacement Therapy Products

Shorts










Latest Videos
Podcasts
Screening
All News

Phase 2b findings show rezpegaldesleukin reduced ACQ-5 scores and improved key AD endpoints in participants with comorbid asthma.

The findings showed evolocumab reduced risk of first major MACE by 25% and risk of first MI by 36%. Full study findings are published in NEJM.

Submission of the sNDA suggests a potential FDA decision on the dextromethorphan-bupropion combination sometime during the first quarter of 2026.

Explore key clinical takeaways from FMX 2025, including updates on CGM, chronic cough, AAA screening, immunization, and more.

ACAAI 2025: Phase 3 results show dupilumab significantly reduced sinus opacification, nasal congestion, and polyp size in patients with AFRS.

Your daily dose of the clinical news you may have missed.

Nearly 40% of REDEFINE 1 participants taking antihypertensive medications reduced or discontinued their blood pressure drugs during the trial, Novo Nordisk reported.

Adults with diabetes often face obstacles to optimal disease management in the workplace. Use this checklist in the clinic to help them navigate the barriers.

New research suggests hormone therapy may increase autoimmune disease risk in postmenopausal women. Dr Jiang discusses early findings and clinical implications.

















































































































































































































































































































